111 related articles for article (PubMed ID: 8179588)
1. Hepatocyte growth factor regulates transforming growth factor alpha in HepG2 hepatic cells.
Shiota G; Nakamura T; Schmidt EV
Biochem Biophys Res Commun; 1994 Apr; 200(2):1099-104. PubMed ID: 8179588
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation.
Masuhara M; Yasunaga M; Tanigawa K; Tamura F; Yamashita S; Sakaida I; Okita K
Hepatology; 1996 Aug; 24(2):323-9. PubMed ID: 8690400
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Egr-1 in HGF-induced elevation of the human 5alpha-R1 gene in human hepatocellular carcinoma cells.
Rui C; Li C; Xu W; Zhan Y; Li Y; Yang X
Biochem J; 2008 Apr; 411(2):379-86. PubMed ID: 18215136
[TBL] [Abstract][Full Text] [Related]
4. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells.
Presnell SC; Stolz DB; Mars WM; Jo M; Michalopoulos GK; Strom SC
Mol Carcinog; 1997 Apr; 18(4):244-55. PubMed ID: 9142219
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor.
Webber EM; FitzGerald MJ; Brown PI; Bartlett MH; Fausto N
Hepatology; 1993 Dec; 18(6):1422-31. PubMed ID: 8244268
[TBL] [Abstract][Full Text] [Related]
6. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
[TBL] [Abstract][Full Text] [Related]
7. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
8. Synergistic enhancement of EGF, but not HGF, stimulated hepatocyte motility by TGF-beta 1 in vitro.
Stolz DB; Michalopoulos GK
J Cell Physiol; 1997 Jan; 170(1):57-68. PubMed ID: 9012785
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
Laird AD; Brown PI; Fausto N
Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
11. Ethanol induces transforming growth factor-alpha expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells.
Kato J; Sato Y; Inui N; Nakano Y; Takimoto R; Takada K; Kobune M; Kuroiwa G; Miyake S; Kohgo Y; Niitsu Y
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):58S-63S. PubMed ID: 12960509
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.
Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA
Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
14. Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):17-24. PubMed ID: 8581343
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state.
Mulder KM
Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells.
Matteucci E; Castoldi R; Desiderio MA
J Cell Physiol; 2001 Mar; 186(3):387-96. PubMed ID: 11169978
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha.
Nakamura N; Shidoji Y; Moriwaki H; Muto Y
Biochem Biophys Res Commun; 1996 Feb; 219(1):100-4. PubMed ID: 8619789
[TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
[TBL] [Abstract][Full Text] [Related]
20. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
